Research Drug that lowers blood sugar also reduces blood vessel dysfunction caused by aging An FDA-approved drug medication intended to lower blood sugar may also prevent vascular constriction and stiffening in aging male mice. Modifying the body’s immune system to help treat Type 1 diabetes Scientists at University of Missouri collaborate with Harvard, Georgia Tech to develop a novel diabetes treatment involving transplanting pancreas cells that produce insulin. Personalizing the fight against flu With the opening of the NextGen Center for Influenza and Emerging Infectious Diseases, MU researcher Henry Wan is working toward a deeper understanding of the flu. Comparative excellence Mizzou 18 recipient and graduate researcher Ryan Dashek turned a love of animals into a passion for comparative medicine. To find the right cure The new Roy Blunt NextGen Precision Health building is part of a larger precision health initiative. NextGen researcher profile: Christian Lorson The associate vice chancellor for research and strategic initiatives has found a logical extension from his previous research to a disease that affects several million people around the world. Researchers Receive $2.3 Million Grant to Weaponize Gut Bacteria Against Liver Cancer A new MU research study will examine how bacteria can optimize immunotherapy treatments. NextGen researchers profile: Haval Shirwan and Esma Yolcu Husband-wife duo Haval Shirwan and Esma Yolcu are harnessing the immune system to fight disease. Researchers Receive More Than $6 Million to Study Diabetes-Related Cardiovascular Disease Two grants will fund diabetes-related cardiovascular disease research into potential treatments to improve vascular function.
